Executives - SERIPHARM Buy the executives list from same sector
M. Gustave Nguema Obame
MD/Chief Operating Officer (Directeur général)
Key figures - SERIPHARM
Participation - SERIPHARM
Shareholders
Activities - SERIPHARM
Other classifications (for some countries)
NAF Rev.2 (FR 2008) : Other research and experimental development on natural sciences and engineering (7219Z)
Conventions Collectives : 2i - Convention collective nationale des industries chimiques et connexes (0044)
Conventions Collectives : 2i - Convention collective nationale des industries chimiques et connexes (0044)
NACE Rev.2 (EU 2008) : Other research and experimental development on natural sciences and engineering (7219)
ISIC 4 (WORLD) : Research and experimental development on natural sciences and engineering (7210)
NACE Rev.2.1 (EU 2025) : Research and experimental development on natural sciences and engineering (7210)
Follow us - SERIPHARM
| Discover more on our Website |
|---|
Kompass membership
| Kompass ID? | FR8538753 |
|---|
Legal information - SERIPHARM
| Type | Headquarters |
|---|---|
| Year established | 1994 |
| Legal form | SAS, société par actions simplifiée |
| Activity (NAF08) | Other research and experimental development on natural sciences and engineering (7219Z) |
| Corporate capital | 2,616,879 EUR |
| SIREN | 397 866 021 |
| SIRET (Siège) | 397 866 021 00025 |
| VAT no |
FR77 397866021 |
| No employees (address) | 50-99 Employees |
| No employees | 50-99 Employees |